“Iski aankh toh
bach jaegi na?”
A father's question before surgery opened a much larger question about clearance, function, childhood, morbidity—and what preservation actually means.
A fourteen-year-old boy returned with a rapidly enlarging tumour on the same side of his face where a major operation had already been performed. His eye was being pushed again.
For his father, who had carried him through years of illness and treatment, the question before another operation was immediate: “Iski aankh toh bach jaegi na?”
The message from paediatric haemato-oncology was similarly simple: try our best to preserve his eye.
Behind those sentences sat a different kind of complexity: recurrent disease, previous surgery, chemotherapy and radiotherapy, altered anatomy, the skull base, the orbit, oncological clearance, function—and a child who may have decades of life ahead of him.
Treatment had appeared to work. Then the disease returned.
The initial disease was a large expansile maxillary tumour diagnosed as PNET. After neoadjuvant chemotherapy, an extended maxillectomy was performed, followed by adjuvant treatment. Subsequent surveillance was reported as reassuring, without evident local or distant disease.
Reconstruction was being considered after a longer disease-free interval. Instead, roughly a year later, a new large mass developed rapidly in the same region, extending above and adjacent to the previously treated territory and again displacing the eye.
When systemic treatment stopped controlling the mass, the decision changed.
Neoadjuvant chemotherapy initially reduced the recurrent tumour. After several cycles, however, the clinical trajectory changed and the mass began enlarging again. Surgery became part of the discussion.
The question was not simply whether the tumour could be removed. It was whether another major operation was reasonable after previous multimodality treatment, what morbidity it might create, what structures might be preserved, and what meaningful oncological benefit could realistically be expected.
What does it mean to save an eye?
Anatomical preservation is only one layer. Vision, ocular movement, exposure, appearance, future growth and development, later reconstruction, treatment effects and oncological safety can all change what “preserved” means.
In a child, morbidity is not experienced only in the weeks after surgery. Its consequences may be carried through education, identity, social life and adulthood. That longer horizon changes the weight of a surgical decision without making oncological safety less important.
The anatomy was no longer normal anatomy.
The recurrent tumour required extensive excision through previously treated territory. Soft tissue and bone were removed, with broad skull-base exposure. The orbit and deeper boundaries demanded deliberate decisions about clearance and preservation.
The resulting defect was supported with a temporalis muscle rotation flap. The eye was retained. The immediate surgical course was uneventful.
The exact operative boundaries, margins and anatomical relationships will be expanded only from the verified operative record. The public narrative should not reconstruct technical detail from memory when a primary record exists.
Five days later, he went home. That is not the end of the story.
He was discharged on the fifth postoperative day with expected morbidity and relief of pain. That describes an early postoperative state—not a final outcome and not a claim of cure.
The clinically important record continues with final pathology, recovery, function, adjuvant planning where applicable, surveillance imaging and what happens over time.
The unanswered questions are part of the case.
Why this tumour recurred in this pattern.
Why chemotherapy initially worked and then appeared to lose control.
Whether the recurrent tumour has the same molecular biology as the original disease.
What long-term vision, orbital function and facial development will be.
What future surveillance will show.
The structure is ready. The source records will fill it.
This encounter already has a defined evidence spine. Until primary records are added, AskSushruta should distinguish narrative context from verified documentary evidence and should not infer missing pathology, imaging, treatment or margin details.
01 · Original pathologyPending source record
02 · Recurrent pathologyPending source record
03 · Imaging chronologyPending source records
04 · Chemotherapy coursePending source record
05 · Operative recordPending source record
06 · ReconstructionPending source record
07 · Postoperative & follow-upPending longitudinal record
This entry can change when the evidence changes.
Pathology, imaging, operative documentation and follow-up can deepen or correct this narrative. AskSushruta should answer from those verified layers when available—and say when the record cannot answer a question.
Publication note: This is a de-identified educational narrative. Because the patient is a minor and the disease pattern may itself be identifying, additional clinical detail, dates, images and records should remain outside the public layer unless appropriate consent and privacy review are complete.
← Back to Journal